BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 28579397)

  • 1. Meta-analysis of heparin therapy for preventing venous thromboembolism in acute spinal cord injury.
    Liu Y; Xu H; Liu F; Lv Z; Kan S; Ning G; Feng S
    Int J Surg; 2017 Jul; 43():94-100. PubMed ID: 28579397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin for venous thromboembolism prophylaxis in patients with acute spinal cord injury: a systematic review and meta-analysis.
    Chen HL; Wang XD
    Spinal Cord; 2013 Aug; 51(8):596-602. PubMed ID: 23689387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study.
    Worley S; Short C; Pike J; Anderson D; Douglas JA; Thompson K
    J Spinal Cord Med; 2008; 31(4):379-87. PubMed ID: 18959355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WITHDRAWN: Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction).
    Alikhan R; Cohen AT
    Cochrane Database Syst Rev; 2010 Feb; (2):CD003747. PubMed ID: 20166070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and comparative efficacy of initiating low-molecular-weight heparin within 24 hours of injury or surgery for venous thromboembolism prophylaxis in patients with spinal cord injury: a prospective TRACK-SCI registry study.
    Lui A; Park C; Chryssikos T; Radabaugh H; Patel A; Aabedi AA; Ferguson AR; Torres Espin A; Mummaneni PV; Dhall SS; Duong-Fernandez X; Saigal R; Chou A; Pan J; Singh V; Hemmerle DD; Kyritsis N; Talbott JF; Pascual LU; Huie JR; Whetstone WD; Bresnahan JC; Beattie MS; Weinstein PR; Manley GT; DiGiorgio AM
    Neurosurg Focus; 2023 Oct; 55(4):E17. PubMed ID: 37778033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction).
    Alikhan R; Cohen AT
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003747. PubMed ID: 19588346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction).
    Alikhan R; Bedenis R; Cohen AT
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003747. PubMed ID: 24804622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Ferrante N; Otten HM; Cuccurullo F; Rutjes AW
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008500. PubMed ID: 22336844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboprophylaxis for trauma patients.
    Barrera LM; Perel P; Ker K; Cirocchi R; Farinella E; Morales Uribe CH
    Cochrane Database Syst Rev; 2013 Mar; (3):CD008303. PubMed ID: 23543562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
    Beitland S; Sandven I; Kjærvik LK; Sandset PM; Sunde K; Eken T
    Intensive Care Med; 2015 Jul; 41(7):1209-19. PubMed ID: 25971389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Rasmussen MS; Jørgensen LN; Wille-Jørgensen P
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative Pharmacological Thromboprophylaxis in Patients With Cancer: A Systematic Review and Meta-analysis.
    Guo Q; Huang B; Zhao J; Ma Y; Yuan D; Yang Y; Du X
    Ann Surg; 2017 Jun; 265(6):1087-1093. PubMed ID: 27849664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness and safety of LMWH for preventing thrombosis in patients with spinal cord injury: a meta-analysis.
    Lin Z; Sun Y; Xue H; Chen L; Yan C; Panayi AC; Mi B; Liu G
    J Orthop Surg Res; 2021 Apr; 16(1):262. PubMed ID: 33853656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients: A Systematic Review and Meta-analysis.
    Tran A; Fernando SM; Carrier M; Siegal DM; Inaba K; Vogt K; Engels PT; English SW; Kanji S; Kyeremanteng K; Lampron J; Kim D; Rochwerg B
    Ann Surg; 2022 Jan; 275(1):19-28. PubMed ID: 34387202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative prophylaxis of venous thromboembolism (VTE) in patients undergoing high ligation and stripping of the great saphenous vein (GSV).
    Wang H; Sun Z; Jiang W; Zhang Y; Li X; Wu Y
    Vasc Med; 2015 Apr; 20(2):117-21. PubMed ID: 25601917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.